|
[½»Á÷]
Ò»ÆðgetÈË-ÊóǶºÏ¿¹ÌåÖƱ¸ÖªÊ¶µã
ÈË-ÊóǶºÏ¿¹Ì壬¼´¿¹ÌåµÄ¿É±äÇøÀ´×ÔÊ󵥿Ë¡¿¹Ì壬¶øºã¶¨ÇøÔòÀ´×ÔÈ˵Ŀ¹Ìå¡£ËüÊÇͨ¹ý´ÓÔÓ½»Áöϸ°û·ÖÀë³ö¹¦ÄÜÐԿɱäÇø»ùÒò£¬ÓëÈËIgºã¶¨Çø»ùÒòÁ¬½Ó£¬²åÈëÊʵ±±í´ïÔØÌ壬תȾËÞÖ÷ϸ°û±í´ï²úÉú¡£Ç¶ºÏ¿¹Ìå¼È±£ÁôÁËÇ×±¾¿¹ÌåÌØÒìÐÔ½áºÏ¿¹ÔµÄÄÜÁ¦£¬ÓÖ´ó´ó¼õÉÙÁËÊóÔ´ÐÔÔÚÈËÌåÄÚµÄÃâÒßÔÐÔ,Æä°ëË¥ÆÚÃ÷ÏÔÑÓ³¤£¬ÇÒÔڽ鵼CDC¼°ADCC·½ÃæÒàÃ÷ÏÔÔöÇ¿¡£
ÈË-ÊóǶºÏ¿¹ÌåµÄÓ¦ÓÃ
ǶºÏ¿¹ÌåÄ¿Ç°Ö÷ÒªÓÃÓÚÒ©ÎïÖÎÁÆ·½Ã棬ÓëÊó¿¹Ïà±È£¬Ç¶ºÏ¿¹Ìå¼È±£ÁôÁËÊóÔ´¿É±äµÄ¸ßÇ׺ÍÐÔ£¬ÓÖ¾ßÓÐÈËFc¶ÎµÄ¶àÖÖÃâÒßɱÉ˹¦ÄÜ£¬´Ó¶ø´ó´ó½µµÍÁËÈË¿¹Êó¿¹Ìå·´Ó¦µÄ·¢Éú¼¸ÂÊ£¬¸ÄÉÆÁËÁÙ´²ÖÎÁÆЧ¹û£¬ÓëÆäËüС·Ö×Ó»ùÒò¹¤³Ì¿¹ÌåÏà±È£¬Ç¶ºÏ¿¹Ìå×÷ΪÍê³ÉµÄ¿¹Ìå·Ö×Ó£¬ÔÚÌåÄÚ°ëÊÙÆÚ¸ü³¤£¬²¢¾ßÓÐÈËFc¶ÎµÄ¶àÖÖÃâÒßɱÉ˹¦ÄÜ¡£
ÖƱ¸·½·¨
1.²ÄÁÏ
´ó³¦¸Ë¾úDH5a£¬´ó³¦¸Ë¾ú¸ÐÊÜ̬ϸ°û£¬TA¿Ë¡ÔØÌåT-Easy Vector£¬ º¬ÐźÅëļ°ÖØÁ´¡¢ÇáÁ´ºã¶¨Çø»ùÒòµÄÖÊÁ£pAc-K-CH3£¬ ·ÖÃÚµ¥¿¹µÄÔÓ½»Áöϸ°û£¬ÕæºË±í´ïÔØÌåpcDNA3.1,СÊó¹ÇËèÁöϸ°ûSp2/0¡£
2.Ö÷ÒªÊÔ¼Á
°±ÜÐÎ÷ÁÖÄÆ£¬ÏÞÖÆÐÔÄÚÇÐø£¬T4 DNAÁ¬½Óø£¬Taq DNAø£¬Trizol RNAÌáÈ¡ÊÔ¼ÁºÐ£¬·´×ªÂ¼PCRÊÔ¼ÁºÐ£¬ÇíÖ¬ÌÇ£¬ÐữÒÒ¶§(EB), dNTPs, DNA Markes DNAÄý½º»ØÊÕÊÔ¼ÁºÐ£¬ÖÊÁ£³éÌáÊÔ¼ÁºÐ£¬Ì¥Å£ÑªÇ壬ÎÞѪÇåÅàÑøÒº£¬¶þ¼×ÑÇ·ã(DMSO),תȾÊÔ¼ÁºÐLieitaminen 2000 MTx,¿¹Ô£¬Ñò¿¹ÈËIgG FcƬ¶ÎHRPø±ê¿¹Ìå¡£
3.Ö÷ÒªÒÇÆ÷
µÍθßËŲ̀ʽÀëÐÄ»ú£¬ºãÎÂÒ¡´²£¬ ºãÎÂˮԡÏ䣬 ˮƽʽµçÓ¾ÒÇ, PCRÀ©ÔöÒÇ£¬×ÏÍâ·Ö¹â¹â¶È¼Æ£¬×ÏÍâ͸ÉäÒÇ£¬co,ÅàÑøÏ䣬µ¹ÖÃÏÔ΢¾µ£¬½à¾»¹¤×÷̨£¬Ã¸±êÒÇ¡£
¹Ø¼ü¼¼ÊõÓë·½·¨
1. ¿É±äÇø»ù䦿Ë¡
1.1 RNAÌáÈ¡¼°·´×ªÂ¼
È¡¶ÔÊýÉú³¤ÆÚµÄÔÓ½»Áöϸ°ûÖêÔ¼107¸öϸ°û,°´ÕÕTrizo1RNAÌáÈ¡ÊÔ¼ÁºÐµÄ˵Ã÷Êé³éÌáϸ°ûµÄ×ÜRNA,ÔÙ½øÐÐRTPCRÀ©Ôö£¬»ØÊÕ´¿»¯À©Ôö²úÎﱸÓá£
1.2 À©ÔöÇáÁ´¡¢ÖØÁ´µÄVÇø»ùÒò
¸ù¾ÝOrlandiµÈ(1989)Éè¼ÆµÄÀ©ÔöСÊó¿É±äÇø»ùÒòµÄÒýÎÒÔÉÏÊöÀ©Ôö²úÎïΪģ°åÀ©Ôö¿¹Ìå»ùÒòµÄ¿É±äÇø¡£»ØÊÕÖØÁ´VH (Ô¼360 bp)¡¢ ÇáÁ´VL (Ô¼330 bp)Ƭ¶Î£¬²åÈëTeasyÔØÌ壬¸÷ËÍ3·ÝÑùÆ·²âÐò¡£²âÐòËùµÃÐòÁÐÔÚGeneBankºËËáÊý¾Ý¿âÖнøÐзÖÀ༰ͬԴÐÔ·ÖÎö¡£
Á½¶Ë¼ÓÈëøÇÐλµã
¸ù¾Ý.ÉÏÊöPCR²úÎïÐòÁÐÉè¼Æº¬Ã¸ÇÐλµãµÄÒýÎÔٴνøÐÐÀ©Ôö£¬ÒÔʹ¿¹Ìå¿É±äÇø»ùÒòƬ¶Î¾ßÓÐÓëÔØÌåÏàÎǺϵÄøÇÐλµã£¬±ãÓÚ²åÈë±í´ïÔØÌå¡£»ØÊÕ´¿»¯À©Ôö²úÎﱸÓá£
2.ǶºÏ¿¹Ìå±í´ïÔØÌå¹¹½¨
¸ÄÔ캬ºÅëļ°ÈËIgÖØÁ´ºÍÇáÁ´CÇø»ùÒòƬ¶ÎµÄµ¥¿Ë¡λµãÉè¼Æº¬ÖØÁ´ÐźÅëÄÆðʼλµãÐòÁм°Ã¸ÇÐλµãNhe IµÄÉÏÓÎÒýÎïHLF(KOZAK+4G,¼´GCCGCCATGG)£¬ºÍº¬Xho I λµãµÄÏÂÓÎÒýÎïHLR£¬ÒÔÖÊÁ£pAc-K-CH3Ϊģ°å£¬À©Ôö³öÖØÁ´ÐźÅëÄ»ùÒòƬ¶Î;Éè¼Æº¬Xho I ºÍKpn I λµãÉÏÓÎÒýÎïHCF,ºÍº¬Furin(RKRR)ÐòÁм°Ã¸ÇÐλµãXba I µÄÏÂÓÎÒýÎïHCR,ÒÔÖÊÁ£pAc-K-CH3Ϊģ°å£¬À©Ôö³öÖØÁ´ºã¶¨Çø»ùÒòƬ¶ÎƬ¶Î;ÓÃXho 1 Á¬½ÓÉÏÊöƬ¶ÎµÃµ½º¬ÖØÁ´ÐźÅëÄ¡¢Mcs¼°ÖØÁ´ºã¶¨ÇøµÄ»ùÒòƬ¶Î¡£Éè¼Æº¬Ã¸ÇÐλµãApa IµÄÉÏÓÎÒýÎïLLF,ºÍº¬EcoR IλµãµÄÏÂÓÎÒýÎïLLR,ÒÔÖÊÁ£pAc-1-CH3Ϊģ°å£¬À©Ôö³öÇáÁ´ÐźÅëÄ»ùÒòƬ¶Î;Éè¼Æº¬EcoR IºÍHind IIλµãÉÏÓÎÒýÎïLCF£¬ºÍº¬Pme I µÄÏÂÓÎÒýÎïLCR£¬ÒÔÖÊÁ£pAc-K-CH3Ϊģ°å£¬À©Ôö³öÇáÁ´ºã¶¨Çø»ùÒòƬ¶ÎƬ¶Î£¬ÓÃEcoR IÁ¬½ÓÉÏÊöƬ¶ÎµÃµ½º¬ÇáÁ´ÐźÅëÄ¡¢MCS¼°ÇáÁ´ºã¶¨ÇøµÄ»ùÒòƬ¶Î¡£
¹¹½¨º¬ºÅëļ°ÈËIgÖØÁ´ºÍÇáÁ´CÇø»ùÒòƬ¶Î±í´ï¿ÕÔØÌå
Óúϳɵĺ¬Ã¸ÇÐλµã(Xba IºÍApa I )µÄ2AÐòÁÐÁ¬½Ó.ÉÏÊöÖØ¡¢ÇáÁ´£¬µÃµ½º¬ÐźÅëļ°ÈËIgÖØÁ´ºÍÇáÁ´CÇø»ùÒòµÄ»ùÒòƬ¶ÎLigC (Leader + Ig Constant È»ºóÓëNheIºÍPme I˫øÇйýµÄpcDNA3.1-CA´óƬ¶ÎÁ¬½Ó£¬¼´µÃµ½Ç¶ºÏ¿¹ÌåÕæºËË«±í´ïÔØÌåpcDNA3.1-CA (chimeric antibody, CA¡£
˫øÇбí´ïÔØÌåpcDNA3.1-CAºÍ´¿»¯µÄVL£¬¾ÇíÖ¬ÌÇÄý½ºµçÓ¾·ÖÀë´¿»¯Ä¿µÄƬ¶Îºó£¬Á¬½Ó¡¢×ª»¯´ó³¦¸Ë¾ú£¬É¸Ñ¡³öpcDNA3.1-CA-VLÑôÐÔ¿Ë¡£¬¸»¼¯ÅàÑøºóÌáÈ¡ÖÊÁ£½øÐÐøÇмø¶¨¡£È»ºó£¬Ë«Ã¸Çбí´ïÔØÌåpcDNA3.1-CA-VLºÍ´¿»¯µÄVH,·ÖÀë´¿»¯ÏàÓ¦µÄøÇÐƬ¶Î£¬Öظ´ÉÏÊö²½Ö裬¹¹½¨³ÉÖØ×é±í´ïÔØÌåpcDNA3.1-CA-XX (¿¹Ôµ¥´ÊµÄÊ××Öĸ)¡£
3.תȾSp2/0ϸ°û
½ÓÖÖÊÊÁ¿Sp2/0ϸ°ûÓÚÅàÑøÆ¿ÖУ¬ÅàÑø12 hºóÓô¿»¯µÄÔØÌåpcDNA3.1-CA-XX DNA,²ÉÓÃLipofectamine 2000ÊÔ¼ÁתȾ£¬°´ÊÔ¼ÁºÐʹÓÃ˵Ã÷Êé½øÐС£ÉèÖÿÕÔØÌåºÍÎÞÔØÌåµÄϸ°ûΪ¶ÔÕÕ¡£×ªÈ¾72 hºó£¬¼Óº¬MTXµÄÑ¡ÔñÐÔÅàÑø»ù½øÐÐɸѡ¡£2Öܺó½«Éú³¤³öµÄÑôÐÔ¿Ë¡ÀûÓÃÓÐÏÞÏ¡ÊÍ·¨µ¥¿Ë¡»¯¡£
4.ÑôÐÔ¿Ë¡¼ø¶¨Óëɸѡ.
ÒÔ¼ä½Ó·¨Óÿ¹ÔºÍø±êÑò¿¹ÈËIgGFcƬ¶Î¿¹Ìå¼ì²âǶºÏ¿¹ÌåµÄÌØÒìÐÔ¼°ÖØ×éÐÔ¡£ÒÔÊÊÁ¿¿¹Ô°ü±»Ã¸±ê°å£¬¼Óϸ°ûÅàÑøÉÏÇå·´Ó¦ºó£¬ÔÙ¼ÓÑò¿¹ÈËIgG FcƬ¶Î-HRPø±ê¿¹Ìå(¾ÊóIgÎü¸½¹ý)·õÓý£¬ÏÔÉ«ºó²âA490Îü¹âÖµ¡£
5.¿¹Ì帹ˮÉú²ú
¸¹Ç»ÖÖֲתȾÁöϸ°û,5~7Ììºó³éÈ¡¸¹Ë®¡£-Ö»ÖÖÖ²ÔÓ½»Áöϸ°ûµÄСÊóÓÐʱ¿É²úÉú¶à´ï10mlµÄ¸¹Ë®¡£Íõ˶µÈ(2003 )±¨µÀ³Æ´Ó¸¹Ë®ÖлñµÃµÄǶºÏ¿¹Ìå²úÁ¿¿É´ï1~2 mg/mlb |
|